间质性肺疾病的家庭监测
本文综述了间质性肺疾病(ILD)家庭监测的应用经验与挑战。智能手机和互联网普及及COVID-19疫情加速了远程监测在ILD患者中的推广。家庭监测有望改善专科可及性、减轻医疗系统负担、识别疾病恶化并简化临床试验,但技术、分析和实施问题仍需解决。
要点
- 家庭血氧、活动追踪和咳嗽监测等设备在ILD中应用逐渐增多。
- 家庭监测可识别急慢性加重、指导治疗并简化临床试验。
- 技术、分析和实施挑战仍是推广家庭监测的主要障碍。
核心结论
- 家庭监测在ILD中具有改善诊疗和研究的潜力,但需应对技术、分析和实施挑战。
研究设计与样本
- 本文为系列综述,总结ILD家庭监测的经验、挑战与未来展望。
主要发现
- 家庭血氧仪、活动追踪器和咳嗽监测器等设备的研究已出现。
- 家庭监测可改善专科可及性、减轻医疗系统负担、提高生活质量、识别疾病加重、指导治疗并简化临床试验。
- 技术、分析和实施问题已显现。
临床怎么用
- 可利用家庭监测识别ILD患者急性和慢性疾病恶化并指导治疗决策。
- 家庭监测可简化临床试验并改善专科医疗可及性。
局限性
- 家庭监测存在技术、分析和实施方面的挑战与局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The widespread use of smartphones and the internet has enabled self-monitoring and more hybrid-care models. The COVID-19 pandemic has further accelerated remote monitoring, including in the heterogenous and often vulnerable group of patients with interstitial lung diseases (ILDs). Home monitoring in ILD has the potential to improve access to specialist care, reduce the burden on health-care systems, improve quality of life for patients, identify acute and chronic disease worsening, guide treatment decisions, and simplify clinical trials. Home spirometry has been used in ILD for several years and studies with other devices (such as pulse oximeters, activity trackers, and cough monitors) have emerged. At the same time, challenges have surfaced, including technical, analytical, and implementational issues. In this Series paper, we provide an overview of experiences with home monitoring in ILD, address the challenges and limitations for both care and research, and provide future perspectives. VIDEO ABSTRACT.
引用
- Wijsenbeek MS, Moor CC, Johannson KA, et al. Home monitoring in interstitial lung diseases. Lancet Respir Med. 2022. PMID: 36206780. doi:10.1016/S2213-2600(22)00228-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。